Yahiya Y. Syed

Elinzanetant in moderate to severe menopausal vasomotor symptoms: a profile of its use

Elinzanetant (Lynkuet®), an oral selective dual neurokinin-1 (NK-1) and neurokinin-3 (NK-3) receptor antagonist, is an important non-hormonal treatment option for moderate to severe vasomotor symptoms (VMS) associated with menopause. It is the first dual NK-targeted therapy appro...